No WHO Pandemic Preparedness Treaty Without Senate Approval Act
- Bill Number
- H.R. 4207
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- International Affairs
- Status
- Introduced
- Latest Action
- 2025-06-26: Referred to the House Committee on Foreign Affairs.
- Last Updated
- 2025-12-05T21:53:34Z
AI-Generated Summary
Purpose of the Legislation
This bill, titled the "No WHO Pandemic Preparedness Treaty Without Senate Approval Act," aims to ensure that any international agreement on pandemic prevention, preparedness, and response adopted by the World Health Assembly (WHA)—the decision-making body of the World Health Organization (WHO)—must be treated as a formal treaty under the U.S. Constitution. This requires Senate approval by a two-thirds vote, preventing the executive branch from entering such agreements without congressional oversight.
Key Provisions
- Findings (Section 2): The bill outlines historical context, including former President Trump's 2020 attempt to withdraw the U.S. from the WHO due to perceived mismanagement of the COVID-19 pandemic and undue influence from China; President Biden's reversal of that withdrawal; the establishment of an Intergovernmental Negotiating Body (INB) in 2021 to draft a pandemic agreement; delays in finalizing the agreement; and criteria from the State Department's Foreign Affairs Manual for distinguishing treaties from executive agreements (e.g., national impact, need for congressional legislation, and past U.S. practices).
- Sense of Congress (Section 3): Expresses congressional concerns about public skepticism toward the WHO's independence (especially from China), urges treating the INB's agreement as a treaty due to its broad scope (covering capacities, equitable access to health tools, financing, and WHO empowerment), and states that without Senate approval, the U.S. should not join or implement such an agreement.
- Treaty Requirement (Section 4): Declares any WHA convention, agreement, or instrument on pandemics resulting from the INB's work to be a treaty, subject to Article II, Section 2, Clause 2 of the U.S. Constitution, which mandates Senate advice and consent by a two-thirds majority.
- Policy on Taiwan (Section 5): Affirms U.S. support for Taiwan's full participation in the WHO, despite its exclusion from WHO membership.
Significant Changes to Existing Law
- The bill overrides the executive branch's discretion to classify international health agreements as non-binding executive agreements (which do not require Senate approval). Instead, it mandates treaty status for WHO pandemic instruments, aligning with State Department criteria but applying them rigidly to prevent bypassing Senate involvement.
- It builds on but does not alter the 1948 joint resolution governing U.S. WHO membership; however, it introduces a new congressional check on future WHO-related commitments.
Potential Impacts
- Government Agencies: The State Department and executive branch would lose flexibility in negotiating and implementing WHO agreements, potentially delaying U.S. involvement in global health initiatives. This could strain resources for treaty ratification processes.
- Citizens: U.S. public health responses to future pandemics might be affected if agreements on equitable access to vaccines, diagnostics, or funding are stalled without Senate approval, though it addresses public distrust by ensuring congressional vetting.
- International Relations: Could complicate U.S.-WHO relations and multilateral efforts on pandemics, signaling reduced trust in the organization. It may encourage other nations to proceed without U.S. input, while the Taiwan provision reinforces U.S. support for Taiwan amid tensions with China, potentially improving ties with Taiwan but escalating friction with Beijing.
Main Stakeholders Affected
- U.S. Congress (Senate): Gains enhanced authority over international health agreements, requiring a supermajority vote for approval.
- Executive Branch (President, State Department): Faces restrictions on independent action in WHO negotiations, potentially limiting diplomatic agility.
- World Health Organization and Member States: U.S. participation in pandemic agreements becomes contingent on Senate consent, which could hinder global consensus and implementation.
- U.S. Citizens and Public Health Advocates: Benefits from safeguards against perceived WHO overreach but risks slower access to international health resources.
- Taiwan: Receives explicit U.S. backing for WHO involvement, aiding its health security amid exclusion from the organization.
Notable Legal, Constitutional, or Political Implications
- Constitutional: Reinforces the Senate's treaty ratification power under Article II, preventing executive overreach in international commitments that could affect national sovereignty, such as health policy or funding obligations. It invokes constitutional balance without challenging WHO membership itself.
- Legal: Applies State Department guidelines (e.g., assessing agreements' national impact) to deem the pandemic instrument a treaty, potentially setting precedent for other international accords but risking legal challenges if seen as infringing on executive foreign affairs authority.
- Political: Reflects bipartisan concerns (sponsored by Republicans) about WHO impartiality and China's influence, amid U.S. political divides on global institutions post-COVID. It could polarize debates on U.S. global leadership, emphasizing "America First" skepticism toward multilateralism while supporting allies like Taiwan.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Tiffany, Thomas P. [R-WI-7]
Cosponsors (12)
Rep. Wied, Tony [R-WI-8], Rep. Moolenaar, John R. [R-MI-2], Rep. Hageman, Harriet M. [R-WY-At Large], Rep. Norman, Ralph [R-SC-5], Rep. Cloud, Michael [R-TX-27], Rep. Tenney, Claudia [R-NY-24], Rep. Crenshaw, Dan [R-TX-2], Rep. Crane, Elijah [R-AZ-2], Rep. Stauber, Pete [R-MN-8], Rep. Gosar, Paul A. [R-AZ-9], Rep. Guest, Michael [R-MS-3], Rep. Miller, Mary E. [R-IL-15]
Recent Actions
- 2025-06-26: Referred to the House Committee on Foreign Affairs.
- 2025-06-26: Introduced in House
- 2025-06-26: Introduced in House
Bill Versions
- No WHO Pandemic Preparedness Treaty Without Senate Approval Act — issued 2025-06-26 — PDF (8 pages)